MARC Record from marc_columbia

LEADER: 02185cam a2200457 a 4500
001 3916999
005 20221027001231.0
008 850725t19851985gw a b 101 0 eng
010 $a 85002570
020 $a0387151079 (pbk.)
035 $a(OCoLC)11650661
035 $a(OCoLC)ocm11650661
035 $a(CStRLIN)NYCM85-B3124
035 $9ADG9335HS
035 $a(NNC)3916999
035 $a3916999
040 $dCStRLIN$dNNC-M
050 00 $aRC684.N56$bI57 1984
082 0 $a616.1/2061$219
111 2 $aInternational Symposium on Mononitrates$d(1984 :$cMontreux, Switzerland)$0http://id.loc.gov/authorities/names/n84157241
245 10 $aMononitrates :$b[International Symposium on Mononitrates, Montreux, Switzerland, June 14-16, 1984] /$cedited by Jay N. Cohn and R. Rittinghausen.
260 $aBerlin ;$aNew York :$bSpringer-Verlag,$c[1985], ©1985.
300 $axi, 320 pages :$billustrations ;$c24 cm.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
490 1 $aInternational Boehringer Mannheim symposia
504 $aIncludes bibliographies and index.
650 0 $aNitrates$xTherapeutic use$vCongresses.
650 0 $aCoronary heart disease$xChemotherapy$vCongresses.
650 0 $aHeart failure$xChemotherapy$vCongresses.
650 0 $aNitrates$xPhysiological effect$vCongresses.
650 2 $aCoronary Disease$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D003327Q000188
650 2 $aHeart Failure$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D006333Q000188
650 2 $aIsosorbide Dinitrate$xanalogs & derivatives.$0https://id.nlm.nih.gov/mesh/D007548Q000031
650 2 $aVasodilator Agents$xpharmacology.$0https://id.nlm.nih.gov/mesh/D014665Q000494
650 2 $aVasodilator Agents$xtherapeutic use.$0https://id.nlm.nih.gov/mesh/D014665Q000627
655 2 $aCongress.$0https://id.nlm.nih.gov/mesh/D016423
700 1 $aCohn, Jay N.$0http://id.loc.gov/authorities/names/n82216463
700 1 $aRittinghausen, R.$q(Reiner)$0http://id.loc.gov/authorities/names/n84157242
830 0 $aInternational Boehringer Mannheim symposia.$0http://id.loc.gov/authorities/names/n42013532
852 00 $boff,hsl$hRC684.N56$iIn8 1984